KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Other Operating Expenses (2016 - 2025)

LifeMD (LFMD) has disclosed Other Operating Expenses for 11 consecutive years, with -$5.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 49.83% year-over-year to -$5.5 million, compared with a TTM value of $76.7 million through Dec 2025, up 26.61%, and an annual FY2025 reading of $76.7 million, up 24.94% over the prior year.
  • Other Operating Expenses was -$5.5 million for Q4 2025 at LifeMD, down from $31.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $33.5 million in Q1 2025 and bottomed at -$11.0 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $19.4 million, with a median of $22.4 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses skyrocketed 733.41% in 2023, then crashed 145.67% in 2024.
  • Year by year, Other Operating Expenses stood at $23.8 million in 2021, then increased by 1.49% to $24.2 million in 2022, then dropped by 0.4% to $24.1 million in 2023, then plummeted by 145.67% to -$11.0 million in 2024, then surged by 49.83% to -$5.5 million in 2025.
  • Business Quant data shows Other Operating Expenses for LFMD at -$5.5 million in Q4 2025, $31.4 million in Q3 2025, and $17.3 million in Q2 2025.